Install
- 253articles · 30d
- 2+ day agolatest article
- Aug 17, 2026earliest in window
- 2%with images
- 348avg words
- Economy, Business & Finance 159
- Finance & Business 100
- Business & Industrial 65
- News 58
- Medical 37
- Health & Wellness 33
- Industrial 33
- Science & Technology 22
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
FDA Clearance of Quantum BioPharma's Lucid-MS Marks First Myelin-Repair Approach to Multiple Sclerosis
3+ day, 1+ hour ago (265+ words) Today’s MS treatments can slow disease progression but none halt it outright or restore lost function. Nearly one million people in the United States and close to 2.9 million worldwide live with the condition, which steadily erodes mobility, eyesight and basic…...
SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program with SSi Mantra 3.0
2+ day, 20+ hour ago (398+ words) citybuzz - SS Innovations International Inc. (NASDAQ: SSII) has announced the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo, utilizing the company’s SSi Mantra 3.0 surgical robotic system. The inaugural procedure was a robotic-assisted left internal mammary…...
Earth Science Tech's Integrated Healthcare Platform Drives Revenue Growth and Debt Reduction
3+ day, 1+ hour ago (307+ words) citybuzz - Earth Science Tech Inc. (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative, combining compounding pharmacy, telemedicine, clinical support, and fulfillment capabilities. Its B2B and B2C business model allows the…...
Quantum BioPharma Advances Multiple Sclerosis Drug Lucid-MS Toward Phase 2 Trial After FDA Clearance
3+ day, 27+ min ago (521+ words) citybuzz - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) is advancing its lead multiple sclerosis drug candidate, Lucid-MS, toward a randomized, double-blind, placebo-controlled Phase 2 clinical trial following clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration…...
FDA Clearance of Quantum BioPharma's Lucid-MS Marks First Myelin-Repair Approach in MS
3+ day, 50+ min ago (331+ words) citybuzz.co Quantum BioPharma Ltd. (NASDAQ: QNTM) has received U.S. Food and Drug Administration clearance to launch a phase 2 trial of Lucid-MS, a patented, first-in-class candidate for multiple sclerosis. The clearance sets up what would be the first time a drug…...
Earth Science Tech Builds Self-Sustaining Healthcare Conglomerate Through Vertical Integration
3+ day, 23+ hour ago (318+ words) The company’s core value proposition lies in seamlessly integrating patient care, from initial consultations via telemedicine and telehealth platforms to clinical support, compounding pharmacy operations, and direct-to-patient fulfillment. This integrated approach allows Earth Science Tech to serve both B2B and B2C segments,…...
GeoVax Welcomes Global Mpox Vaccine Stockpile, Highlights GEO-MVA's Role in Diversifying Supply
4+ day, 5+ hour ago (455+ words) citybuzz - ATLANTA, GA — GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company, has welcomed the launch of a new global mpox vaccine stockpile, an initiative funded by Gavi, the Vaccine Alliance, and coordinated by the International Coordinating Group (ICG) on…...
YDC 2026 Winners Crowned at CENTRESTAGE Grand Finale
4+ day, 3+ hour ago (460+ words) citybuzz - The Hong Kong Young Fashion Designers’ Contest 2026 (YDC) concluded on 5 September with a spectacular grand finale at CENTRESTAGE, Asia’s premier fashion event, organized by the Hong Kong Trade Development Council (HKTDC) and sponsored by the Cultural and Creative Industries…...
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15
4+ day, 3+ hour ago (375+ words) citybuzz - Silo Pharma Inc. (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, announced that its representatives will participate in the IPAC-RS 2026 Nasal Innovation Forum, scheduled for September 16-17, 2026, in Jersey City, New Jersey. The forum…...
Retail Expert Mitch Gould to Share Decades of Experience at ECRM Vitamin, Weight Management & Sports Nutrition Session
4+ day, 7+ hour ago (525+ words) citybuzz - Mitch Gould, founder and CEO of Nutritional Products International (NPI), is set to bring his extensive retail background to the ECRM Vitamin, Weight Management & Sports Nutrition Session, scheduled for Sept. 14-17 in Palm Beach Gardens, Florida. Gould has spent decades…...